JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 29 No. 11 1826-1832
© 1988 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wijns, W.
Right arrow Articles by Beckers, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wijns, W.
Right arrow Articles by Beckers, C.

Accumulation of Polymorphonuclears Leukocytes in Reperfused Ischemic Canine Myocardium: Relation with Tissue Viability Assessed by Fluorine- 18-2-Deoxy glucose Uptake

William Wijns, Jacques A. Melin, Norbert Leners, Augustin Ferrant, André Keyeux, Jacques Rahier, Michel Cogneau, Christian Michel, Anne Bol, Annie Robert, Hubert Pouleur, André Charlier and Christian Beckers

Center of Nuclear Medicine, the Positron Emission Tomography Laboratory, the Division of Cardiology and the Department of Pathology, University of Louvain, Brussels, Belgium

Correspondence: For reprints contact: William Wijns, MD, Positron Emission Tomography Laboratory, Avenue Hippocrate 55, Box 5550, B-1200 Brussels, Belgium.

ABSTRACT

Polymorphonudear leukocytes may participate in reperfusion injury. Whether leukocytes affect viable or only irreversibly injured tissue is not known. Therefore, we assessed the accumulation of 111In-labeled leukocytes in tissue samples characterized as either ischemic but viable or necrotic by metabolic, histochemical, and ultrastructural criteria. Six open-chest dogs received left anterior descending coronary occlusion for 2 hr followed by 4 hr reperfusion. Myocardial blood flow was determined by microspheres and autologous 111In labeled leukocytes were injected intravenously. Fluorine-18-2-deoxyglucose, a tracer of exogenous glucose utilization, was injected 3 hr after reperfusion. The dogs were killed 4 hr after reperfusion. The risk and the necrotic regions were assessed following in vivo dye injection and postmortem tetrazolium staining. Myocardial samples were obtained in the ischemic but viable, necrotic and normal zones, and counted for 111In and 18F activity. Compared to normal,leukocytes were entrapped in necrotic regions(111In activity: 207±73%) where glucose uptake was decreased(26 ± 15%). A persistent glucose uptake, marker of viability, was mainly seen in risk region(135 ± 85%) where leukocytes accumulation was moderate in comparison to normal zone (146 ± 44%). Thus, the glucose uptake observed in viable tissue is mainly related to myocytes metabolism and not to leukocytes metabolism

FOOTNOTES

Presented in part at the 34th Annual Meeting of the Society of Nuclear Medicine, Toronto, 1987.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. R. Bridges
Myocardial laser revascularization: the controversy and the data
Ann. Thorac. Surg., February 1, 2000; 69(2): 655 - 662.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Matsumura, R. W. Jeremy, J. Schaper, and L. C. Becker
Progression of Myocardial Necrosis During Reperfusion of Ischemic Myocardium
Circulation, March 3, 1998; 97(8): 795 - 804.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Maes, F. Van de Werf, J. Nuyts, G. Bormans, W. Desmet, and L. Mortelmans
Impaired Myocardial Tissue Perfusion Early After Successful Thrombolysis : Impact on Myocardial Flow, Metabolism, and Function at Late Follow-up
Circulation, October 15, 1995; 92(8): 2072 - 2078.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1988 by the Society of Nuclear Medicine.